Ayala Pharmaceuticals Inc (ADXS)
0.70
-0.01
(-1.41%)
USD |
OTCM |
Mar 27, 16:00
Ayala Pharmaceuticals Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | -0.002M |
June 30, 2021 | -0.003M |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.019M |
September 30, 2020 | -0.042M |
Date | Value |
---|---|
June 30, 2020 | 0.022M |
March 31, 2020 | 0.182M |
December 31, 2019 | -0.643M |
September 30, 2019 | 0.00 |
June 30, 2019 | -0.62M |
March 31, 2019 | -0.318M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.643M
Minimum
Dec 2019
0.182M
Maximum
Mar 2020
-0.1081M
Average
--
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
Taro Pharmaceutical Industries Ltd | 81.67M |
InspireMD Inc | -0.036M |
BiomX Inc | -0.032M |
Alpha Tau Medical Ltd | -- |
Pluri Inc | 3.919M |
Cash from Investing (Quarterly) Related Metrics
Free Cash Flow Yield | -1.27K% |